Related Experiment Videos
Cardiac autonomic activity and Type II diabetes mellitus
Daniela Manzella1, Giuseppe Paolisso
1Department of Geriatric Medicine and Metabolic Diseases, Second University of Naples, Piazza Miraglia 2, I-80138, Naples, Italy.
Insights
Cardiac autonomic neuropathy (CAN) in diabetes increases risks for silent heart attacks and mortality. Spectral analysis of heart rate variability is a key method for diagnosing CAN due to its practicality and reliability.
Area of Science:
- Cardiology
- Diabetology
- Autonomic Neuroscience
Background:
- Cardiac autonomic neuropathy (CAN) is a frequent diabetes complication.
- Reduced heart rate variability (HRV) indicates impaired cardiovascular autonomic function.
- Diabetic heart dysfunction is often linked to unrecognized cardiac sympathetic issues.
Purpose of the Study:
- To highlight the significance of CAN in diabetes.
- To discuss diagnostic methods for CAN.
- To emphasize the role of HRV in CAN assessment.
Main Methods:
- Review of meta-analyses on CAN and cardiovascular outcomes.
- Description of diagnostic techniques including autonomic function tests, SPECT, and PET.
- Focus on spectral analysis of heart rate variability (HRV).
Main Results:
- Reduced HRV is strongly linked to increased risk of silent myocardial ischemia and mortality in diabetic patients.
- Cardiac sympathetic dysfunction is a major factor in ischemia-induced vascular impairment.
- Spectral analysis of HRV is identified as a primary technique for CAN evaluation.
Conclusions:
- CAN is a critical complication of diabetes with significant prognostic implications.
- HRV spectral analysis offers a cost-effective, user-friendly, and reproducible method for CAN diagnosis.
- Early detection and management of CAN are crucial for improving outcomes in diabetic patients.
Abstract:
CAN (cardiac autonomic neuropathy) is a common complication of diabetes. Meta-analyses of published data demonstrate that reduced cardiovascular autonomic function, as measured by heart rate variability, is strongly associated with an increased risk of silent myocardial ischaemia and mortality. A major problem in ischaemia-induced impairment of vascular performance in the diabetic heart is unrecognized cardiac sympathetic dysfunction. Determining the presence of CAN is based on a battery of autonomic function tests and techniques such as SPECT (single-photon emission computed tomography) and PET (positron emission tomography). Nevertheless, spectral analysis of heart rate variability seems to remain the primary technique in evaluating CAN, due to its low cost, easy use and good intra-individual reproducibility.
Related Concept Videos
Heart Failure II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers